文献速递生殖医学

体外受精临床预测模型质量的系统综述

A systematic review of the quality of clinical prediction models in in vitro fertilisation.
PubMed 文献 · Hum Reprod · 2020-01-01

该研究系统检索1978年至2019年1月的文献,纳入33篇出版物报告35个IVF预测模型,使用CHARMS和TRIPOD评估方法学质量与报告质量。外部验证模型的c-statistics为0.55至0.77,TRIPOD符合率为29%至95%;综述推荐McLernon治疗后模型用于预测最多六个完整周期的累积活产机会。

要点

  • 外部验证的IVF预测模型c-statistics介于0.55至0.77,判别能力有限。
  • 多数模型仅预测单个新鲜周期的妊娠或活产机会,临床相关性不足。
  • McLernon治疗后模型外部验证表现最佳,推荐用于累积活产咨询。

核心结论

  • 综述推荐McLernon治疗后模型用于预测最多六个完整IVF周期的累积活产机会。
  • 该模型需在IVF实践和政策不同的国家进一步外部验证以评估适用性。

研究设计与样本

  • 系统检索OVID MEDLINE、OVID EMBASE和Cochrane library从1978年至2019年1月的原始文章。
  • 纳入报告IVF预测模型开发和或验证的研究,排除涉及供卵、供精和代孕的治疗人群。
  • 使用CHARMS清单提取并批判性评估方法学质量,用TRIPOD 22项清单计算报告符合率。

主要发现

  • 所有纳入研究的TRIPOD符合率范围为29%至95%。
  • 所有外部验证研究的c-statistics范围为0.55至0.77。
  • 多数模型预测单个新鲜周期的妊娠或活产机会,六个模型预测每个治疗周期的机会,三个模型预测累积妊娠或活产。
  • McLernon模型使用英国国家数据开发,TRIPOD评分最高,其治疗后模型外部验证表现最佳。

关键数值与推荐

  • McLernon治疗前和治疗后模型预测每位女性多个完整IVF周期的累积活产机会,完整周期包括同一次卵巢刺激的所有新鲜和冷冻胚胎移植。
  • 综述推荐McLernon治疗后模型作为咨询工具,告知夫妇最多六个完整周期的预测成功机会。

临床怎么用

  • 临床医生应选择最适合患者需求的预测模型进行咨询。
  • 可使用McLernon治疗后模型向夫妇告知最多六个完整周期的累积活产预测机会。
  • 在IVF实践和政策不同的国家应用该模型前需进一步外部验证。

局限性

  • 许多早期IVF预测模型在2015年TRIPOD报告规范发布前开发和验证,影响报告质量评估。
  • 本系统综述有两位作者是McLernon模型文章的作者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the best-quality clinical prediction models in IVF (including ICSI) treatment to inform clinicians and their patients of their chance of success? SUMMARY ANSWER: The review recommends the McLernon post-treatment model for predicting the cumulative chance of live birth over and up to six complete cycles of IVF. WHAT IS KNOWN ALREADY: Prediction models in IVF have not found widespread use in routine clinical practice. This could be due to their limited predictive accuracy and clinical utility. A previous systematic review of IVF prediction models, published a decade ago and which has never been updated, did not assess the methodological quality of existing models nor provided recommendations for the best-quality models for use in clinical practice. STUDY DESIGN, SIZE, DURATION: The electronic databases OVID MEDLINE, OVID EMBASE and Cochrane library were searched systematically for primary articles published from 1978 to January 2019 using search terms on the development and/or validation (internal and external) of models in predicting pregnancy or live birth. No language or any other restrictions were applied. PARTICIPANTS/MATERIALS, SETTING, METHODS: The PRISMA flowchart was used for the inclusion of studies after screening. All studies reporting on the development and/or validation of IVF prediction models were included. Articles reporting on women who had any treatment elements involving donor eggs or sperm and surrogacy were excluded. The CHARMS checklist was used to extract and critically appraise the methodological quality of the included articles. We evaluated models' performance by assessing their c-statistics and plots of calibration in studies and assessed correct reporting by calculating the percentage of the TRIPOD 22 checklist items met in each study. MAIN RESULTS AND THE ROLE OF CHANCE: We identified 33 publications reporting on 35 prediction models. Seventeen articles had been published since the last systematic review. The quality of models has improved over time with regard to clinical relevance, methodological rigour and utility. The percentage of TRIPOD score for all included studies ranged from 29 to 95%, and the c-statistics of all externally validated studies ranged between 0.55 and 0.77. Most of the models predicted the chance of pregnancy/live birth for a single fresh cycle. Six models aimed to predict the chance of pregnancy/live birth per individual treatment cycle, and three predicted more clinically relevant outcomes such as cumulative pregnancy/live birth. The McLernon (pre- and post-treatment) models predict the cumulative chance of live birth over multiple complete cycles of IVF per woman where a complete cycle includes all fresh and frozen embryo transfers from the same episode of ovarian stimulation. McLernon models were developed using national UK data and had the highest TRIPOD score, and the post-treatment model performed best on external validation. LIMITATIONS, REASONS FOR CAUTION: To assess the reporting quality of all included studies, we used the TRIPOD checklist, but many of the earlier IVF prediction models were developed and validated before the formal TRIPOD reporting was published in 2015. It should also be noted that two of the authors of this systematic review are authors of the McLernon model article. However, we feel we have conducted our review and made our recommendations using a fair and transparent systematic approach. WIDER IMPLICATIONS OF THE FINDINGS: This study provides a comprehensive picture of the evolving quality of IVF prediction models. Clinicians should use the most appropriate model to suit their patients' needs. We recommend the McLernon post-treatment model as a counselling tool to inform couples of their predicted chance of success over and up to six complete cycles. However, it requires further external validation to assess applicability in countries with different IVF practices and policies. STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the Elphinstone Scholarship Scheme and the Assisted Reproduction Unit, University of Aberdeen. Both D.J.M. and S.B. are authors of the McLernon model article and S.B. is Editor in Chief of Human Reproduction Open. They have completed and submitted the ICMJE forms for Disclosure of potential Conflicts of Interest. The other co-authors have no conflicts of interest to declare. REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ratna MB, Bhattacharya S, Abdulrahim B, et al. A systematic review of the quality of clinical prediction models in in vitro fertilisation. Hum Reprod. 2020. PMID: 31960915. doi:10.1093/humrep/dez258

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。